Yiling Jiang
5 Papers
Yiling Jiang is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has co-authored 5 publications.
Chat about Author
Papers
Glutamine‐Based Metabolism Normalization and Oxidative Stress Alleviation by Self‐Assembled Bilirubin/V9302 Nanoparticles for Psoriasis Treatment
Xinyu Jiang,Shu-Qi Huang,Wenjin Cai,Pei Wang,Zewei Jiang,Minghui Wang,Linyi Zhang,Pengfei Mao,Lijia Chen,Rui-Hai Wang,Tuyue Sun,Yiling Jiang,Qing Yao,Ruijie Chen,Longfa Kou +14 more
TL;DR: Li et al. as discussed by the authors developed a self-assembly nanoparticle (BVn) with bilirubin (an endogenous antioxidant) and V9302 (a blocker of ASCT2, an amino acid transporter mediating glutamine influx for providing energy and activating mammalian target of rapamycin [mTOR] pathway) to intervene the local metabolism and alleviate oxidative stress for psoriasis treatment.
11
Fe-involved nanostructures act as photothermal transduction agents in cancer photothermal therapy.
TL;DR: Recently, photothermal therapy (PTT), a rising strategy, has gained attention as mentioned in this paper , and many PTT nanostructures incorporating Fe3+ have been developed, but they are still in their infancy and more effort must be devoted to improving their effectiveness.
9
Recombinant protein drugs-based intra articular drug delivery systems for osteoarthritis therapy.
TL;DR: In this article , a review of RPDs with therapeutic potential for OA, and summarizes their research progress on related drug delivery systems, and make proper discussion on the certain keys for optimal development of this area.
7
Comparative analysis of the mutation detection using malignant pleural effusion and blood cell-free DNA samples in lung cancer.
Yaobin Lin,Yiling Jiang,Tao Wang +2 more
TL;DR: In this paper , the difference of MPE and cfDNA in lung cancer-related mutation detection was compared by Fisher's exact test and showed that MPE is considered to bear cancer signatures because it contains tumor cells released from malignancies, thus can be applied in high-throughput sequencing for cancer screening.
ATB0,+-targeted nanoparticles initiate autophagy suppression to overcome chemoresistance for enhanced colorectal cancer therapy.
Zhiwei Chen,Heyan Chen,Wenying Cai,Meng Sun,Zhikai Jiang,Ruijie Lu,Yiling Jiang,Xinyu Jiang,Hailun Zheng,Qing Yao,Kwon Seop Kim,GuangYong Lin,Congying Xie,Maoping Chu,Ruijie Chen,Longfa Kou +15 more
TL;DR: Zhang et al. as mentioned in this paper designed oxaliplatin/berbamine-coloaded, ATB0+-targeted nanoparticles ((O + B)@Trp-NPs) to therapeutically target SLC6A14 (ATB0,+) and inhibit cancer proliferation.